IMO, this announcement does not warrant a "sensitive" anouncement. However I hope it helps steadying the SP.
- Forums
- ASX - By Stock
- NEU
- Ann: Update on trofinetide Phase 3 trial in Rett syndrome
NEU
neuren pharmaceuticals limited
Add to My Watchlist
0.36%
!
$16.54

Ann: Update on trofinetide Phase 3 trial in Rett syndrome, page-4
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
$16.54 |
Change
0.060(0.36%) |
Mkt cap ! $2.076B |
Open | High | Low | Value | Volume |
$16.65 | $16.71 | $16.33 | $202.8K | 12.25K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
3 | 51 | $16.54 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$16.55 | 58 | 6 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 33 | 16.470 |
5 | 168 | 16.460 |
5 | 219 | 16.450 |
6 | 273 | 16.440 |
1 | 52 | 16.430 |
Price($) | Vol. | No. |
---|---|---|
16.500 | 26 | 2 |
16.510 | 91 | 4 |
16.520 | 154 | 3 |
16.530 | 183 | 4 |
16.540 | 157 | 3 |
Last trade - 10.15am 29/07/2025 (20 minute delay) ? |
Featured News
NEU (ASX) Chart |